Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-22 09:05 am Sale | 13D | HALEON PLC ADR HLN | PFIZER INC PFE | 2,062,236,079 22.6% | -892,827,547 (-30.21%) | View |
2024-03-19 8:48 pm Unchanged | 13D | HALEON PLC ADR HLN | PFIZER INC PFE | 2,955,063,626 32% | 0 (Unchanged) | View |
2024-03-15 07:45 am Unchanged | 13G | TOURMALINE BIO INC TRML | PFIZER INC PFE | 1,272,214 4.96% | 0 (Unchanged) | View |
2024-02-14 3:48 pm Purchase | 13G | EFFECTOR THERAPEUTICS INC EFTR | PFIZER INC PFE | 2,243,850 3.47% | 2,243,850 (New Position) | View |
2024-02-14 3:31 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | PFIZER INC PFE | 389,429 0.95% | 389,429 (New Position) | View |
2024-02-14 2:29 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | PFIZER INC PFE | 1,362,499 4.58% | 1,362,499 (New Position) | View |
2024-02-14 2:24 pm Purchase | 13G | CELLECTIS S A SPONSORED ADS CLLS | PFIZER INC PFE | 2,786,924 3.89% | 2,786,924 (New Position) | View |
2024-02-14 2:19 pm Unchanged | 13G | AKERO THERAPEUTICS INC AKRO | PFIZER INC PFE | 2,525,252 4.53% | 0 (Unchanged) | View |
2024-02-13 5:12 pm Purchase | 13G | PFIZER INC PFE | VANGUARD GROUP INC | 506,479,807 8.97% | 4,843,587 (+0.97%) | View |
2024-01-29 5:01 pm Sale | 13D | LONGBOARD PHARMACEUTICALS INC LBPH | PFIZER INC PFE | 0 0% | -3,978,540 (Position Closed) | View |
2024-01-29 1:04 pm Purchase | 13G | PFIZER INC PFE | STATE STREET CORP STT | 287,875,814 5.1% | 2,932,117 (+1.03%) | View |
2024-01-26 11:49 am Sale | 13G | PFIZER INC PFE | BlackRock Inc. BLK | 434,748,255 7.7% | -8,120,506 (-1.83%) | View |
2024-01-19 4:20 pm Unchanged | 13D | HALEON PLC ADR HLN | PFIZER INC PFE | 2,955,063,626 32% | 0 (Unchanged) | View |
2024-01-10 4:12 pm Unchanged | 13D | LONGBOARD PHARMACEUTICALS INC LBPH | PFIZER INC PFE | 3,978,540 11.26% | 0 (Unchanged) | View |
2023-10-27 4:01 pm Purchase | 13G | TOURMALINE BIO INC TRML | PFIZER INC PFE | 1,272,214 6.26% | 1,272,214 (New Position) | View |
2023-10-25 5:29 pm Unchanged | 13D | ALLOGENE THERAPEUTICS INC ALLO | PFIZER INC PFE | 22,032,040 13.14% | 0 (Unchanged) | View |
2023-10-18 4:27 pm Unchanged | 13D | CEREVEL THERAPEUTICS HOLD. INC CERE | PFIZER INC PFE | 27,349,211 15.4% | 0 (Unchanged) | View |
2023-10-10 4:11 pm Unchanged | 13D | HALEON PLC ADR HLN | PFIZER INC PFE | 2,955,063,626 32% | 0 (Unchanged) | View |
2023-09-11 4:08 pm Unchanged | 13D | HALEON PLC ADR HLN | PFIZER INC PFE | 2,955,063,626 32% | 0 (Unchanged) | View |
2023-07-10 09:10 am Purchase | 13G | CARIBOU BIOSCIENCES INC CRBU | PFIZER INC PFE | 4,690,431 7.1% | 4,690,431 (New Position) | View |